Article
Uridine monophosphate synthetase enables eukaryotic de novo NAD+ biosynthesis from quinolinic acid.
The Journal of biological chemistry - 7 Jul 2017
McReynolds Melanie R, Wang Wenqing, Holleran Lauren M, Hanna-Rose Wendy
Abstract excerpt
NAD+ biosynthesis is an attractive and promising therapeutic target for influencing health span and obesity-related phenotypes as well as tumor growth. Full and effective use of this target for therapeutic benefit requires a complete understanding of NAD+ biosynthetic pathways. Here, we report a previously unrecognized role for a conserved phosphoribosyltransferase in NAD+ biosynthesis. Because a required...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
